Doxorubicin Market: Current Analysis and Forecast (2022-2030)
$3999 – $6999
Emphasis on Drug Formulation (Lyophilized Powder and Doxorubicin Injection); Application (Bladder Cancer, Kaposi Sarcoma, Leukemia, Lymphoma, Breast Cancer, and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy); and Region/Country
The Doxorubicin market was valued at USD 1.3 Billion and is expected to grow at a strong CAGR of around 6% during the forecast period (2022-2030). Doxorubicin is a chemotherapy medication used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, and others. It works by stopping the growth and spread of cancer cells. The global doxorubicin market is expected to grow steadily in the coming years. The market growth is influenced by factors such as the increasing incidence of cancer worldwide and the rising demand for effective cancer treatments. Further, the increasing governmental and private player interference in the clinical research of cancer treatment also attributes to the market growth of the doxorubicin market. For instance, as per Clinicaltrial.Gov, Helix BioPharma Corporation is conducting Phase II clinical trials for L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer. This study evaluates the safety and tolerability of escalating doses of L-DOS47 in combination with doxorubicin and preliminary antitumor activity in patients with previously treated advanced pancreatic cancer.
Some of the major players operating in the market include Intas Pharmaceuticals Ltd.; Cipla Inc.; Dr. Reddy’s Laboratories Ltd.; Cadila Pharmaceuticals; Meiji Holdings Co., Ltd.; Johnson & Johnson Private Limited.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; and Baxter Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst drug formulation, doxorubicin injection segment is expected to grow at a considerable rate during the forecast period.”
Based on drug formulation, the market is segmented into lyophilized powder and doxorubicin injection. As per our analysis, the doxorubicin injection segment is expected to grow at a considerable rate during the forecast period. Doxorubicin Injection is administered intravenously (IV) and is used to treat various types of cancer, including breast cancer, ovarian cancer, lung cancer, and others. The injections absorb easily inside the body, and these injections are easily available which is an important factor responsible for the growth of the segment in the doxorubicin market.
“Amongst application, the breast cancer segment held a dominant share in 2021”
Based on the application, the market is segmented into bladder cancer, kaposi sarcoma, leukemia, lymphoma, breast cancer, and others. Amongst these, the breast cancer segment held a dominant share in 2021. The rising incidences of breast cancer are the major factor responsible for the large share of the breast cancer segment in the doxorubicin market. For instance, as per the WHO, in 2020, 2.3 million women were diagnosed with breast cancer worldwide and 685,000 women died due to breast cancer.
“Amongst distribution channel, the online pharmacy segment is expected to grow at a considerable rate during the forecast period.”
Based on the distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. As per our analysis, the online pharmacy segment is expected to grow at a considerable rate during the forecast period. Online pharmacies are becoming increasingly popular in the doxorubicin market, as they provide a convenient and cost-effective option for patients to purchase their medications. Further, the adoption of mobile phones is increasing, which is also an important factor for the rapid growth of the segment.
Doxorubicin Market Report Coverage
“Asia Pacific is expected to grow with the highest CAGR Doxorubicin market during the forecast period.”
Asia Pacific is expected to grow with the highest CAGR Doxorubicin market during the forecast period due to its large population and increasing incidences of cancer in the region are the major catalyzing factors for the market growth of doxorubicin in the region. For instance, as per the Australian Government, In 2020, 48,266 people died from cancer in Australia which include 27,167 men and 21,099 women.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The global Doxorubicin market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|2.1.||Research Process of the Doxorubicin Market|
|2.2.||Research Methodology of the Doxorubicin Market|
|5||GLOBAL DOXORUBICIN MARKET COVID-19 IMPACT|
|6||GLOBAL DOXORUBICIN MARKET REVENUE, 2020-2028F|
|10.1.||North America Doxorubicin Market|
|10.1.3.||Rest of North America|
|10.2.||Europe Doxorubicin Market|
|10.2.6.||Rest of Europe|
|10.3.||Asia-Pacific Doxorubicin Market|
|10.3.6.||Rest of APAC|
|10.4.||Rest of the World Doxorubicin Market|
|12||DOXORUBICIN MARKET OPPORTUNITIES|
|13||DOXORUBICIN MARKET TRENDS|
|14.1.||Demand Side Analysis|
|14.2.||Supply Side Analysis|
|15||VALUE CHAIN ANALYSIS|
|18.1.1.||Porters Fiver Forces Analysis|
|19.1.||Intas Pharmaceuticals Ltd.|
|19.3.||Dr. Reddy’s Laboratories Ltd.|
|19.5.||Meiji Holdings Co., Ltd.|
|19.6.||Johnson & Johnson Private Limited.|
|19.9.||Sun Pharmaceutical Industries Ltd.|
Research Methodology for the Doxorubicin Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Doxorubicin market were the three major steps undertaken to create and analyze the adoption of Doxorubicin in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global Doxorubicin market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the doxorubicin market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the doxorubicin market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as application and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the doxorubicin market. Further, we conducted factor analysis using dependent and independent variables such as drug formulation, application, and distribution channel of the doxorubicin market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Doxorubicin market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global doxorubicin market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of Doxorubicin market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Doxorubicin market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Doxorubicin market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the application and end-user in the global Doxorubicin market.
The main objective of the Global Doxorubicin Market Study
The current & future market trends of the global doxorubicin market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Doxorubicin market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of drug formulation, application, and distribution channel.
- Define and analysis of the regulatory framework for the doxorubicin industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the doxorubicin market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the doxorubicin market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry